Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.

As survival of acute lymphoblastic leukemia (ALL) exceeds 90%, limiting therapy-related toxicity has become a key challenge. Cardio-metabolic dysfunction is a challenge during and after childhood ALL therapy. In a single center study, we measured triglycerides (TG), total cholesterol (TC), high (HDL...

Full description

Bibliographic Details
Main Authors: Pernille Rudebeck Mogensen, Kathrine Grell, Kjeld Schmiegelow, Ulrik Malthe Overgaard, Benjamin Ole Wolthers, Signe Sloth Mogensen, Allan Vaag, Thomas Leth Frandsen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0231209